CompoSecure, Inc. - Class A Common Stock CMPO 深 滬
已收盤 12-12 16:00:00 美东时间
20.22
-0.250
-1.22%
華盛通- 最 高21.0401
- 今 開20.39
- 成交量 86.00万股
- 最 低 20.0401
- 昨 收 20.47
- 總市值 20.62亿
- 52周最高 26.78
- 市盈率 靜 --
- 換手率 0.84%
- 52周最低 9.2438
- 委 比 0.00%
- 總股本 1.02亿
- 歷史最高 26.78
- 量 比 1.04
- 振 幅 4.89%
- 歷史最低 1.3242
- 每 手 1
- 風險率 3.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CompoSecure Faces Legal Challenges Over Proxy Statement
The latest update is out from CompoSecure ( ($CMPO) ). On November 2, 2025, Com...
12-13 06:48
CompoSecure Says Three Separate Complaints Were Filed By Purported Shareholders Of The Co For Negligence & Negligent Misrepresentation And Concealment; Complaints Allege That Proxy Statement Is Materially Incomplete & Misleading, Misrepresents And/Or Omits Material Information; Co Believes Complaints Regarding Are Without Any Merit & That No Supplemental Disclosure Is Required Under Applicable Laws
As previously disclosed, on November 2, 2025, CompoSecure, Inc., a Delaware corporation ("CompoSecure" or the "Company"), and certain of its subsidiaries entered into a Share Purchase Agreement (the
12-13 06:38
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
JP Morgan Maintains Neutral on CompoSecure, Raises Price Target to $22
JP Morgan analyst Reginald Smith maintains CompoSecure (NYSE:CMPO) with a Neutral and raises the price target from $20 to $22.
12-05 01:32
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
CompoSecure Analyst Turns Bullish As Margins Improve, Organic Growth 'Appears Sustainable'
CompoSecure generated healthy margin expansion and accelerating organic growth in the third quarter, according to JPMorgan.
11-13 02:24
JP Morgan Upgrades CompoSecure to Neutral, Raises Price Target to $20
JP Morgan analyst Reginald Smith upgrades CompoSecure (NYSE:CMPO) from Underweight to Neutral and raises the price target from $16 to $20.
11-12 20:11
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
每日全球并购：东山精密完成收购法国GMD集团 | CompoSecure将公布以50亿美元收购赫斯基技术公司的交易（11/4）
-每日资讯- 1、Getty Images收购Shutterstock交易面临英监管机构深度调查 Getty Images计划收购竞争对手Shuttersto...
11-04 20:30
Needham Maintains Buy on CompoSecure, Raises Price Target to $25
Needham analyst John Todaro maintains CompoSecure (NYSE:CMPO) with a Buy and raises the price target from $22 to $25.
11-04 19:10
